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Evaluation of Commercial Slides for Detection of 
Immunoglobulin G against Bartonella henselae by 
Indirect Immunofluorescence 
R. Zbinden 1., N. Michael 1, M. Sekulovski 1, A. von Graevenitz 1, D. Nadal 2 
Four commercial slides were compared with in-house slides for the detection of immu- 
noglobulin G (IgG) against Bartonella henselae in 58 healthy persons from a rural region 
by an indirect immunofluorescence assay. MRL-BA slides (MRL Diagnostics, USA) and 
Virion slides (Virion, Switzerland) with agar-derived Bartonella henselae showed IgG 
titers of >_ 1:256 in 44.8% and 51.7%, respectively, whereas Bion slides (Bios, Germany), 
MRL-Vero slides (MRL Diagnostics), and in-house slides with cell-associated Bar- 
tonella henselae showed such titers in 3.4%, 5.1% and 3.4%, respectively. The MRL- 
Vero slides (Bartonella IgG substrate slides, MRL Diagnostics) were further evaluated 
with 26 patients with cat scratch disease, 20 patients with lymphadenopathy not due 
to cat scratch disease, 100 blood donors from an urban area, and 120 blood donors 
from a mixed urban/rural area. In our mixed urban/rural population the IgG titer of 1:256 
had a sensitivity of 84.6% and a specificity of 93.4% for the serodiagnosis of cat scratch 
disease. Seroprevalence was higher in blood donors from the mixed area (50.8%) than 
from the urban area (37%). MRL-Vero slides were considered useful for the serodiagnosis 
of cat scratch disease by indirect immunofluorescence and have replaced our in-house 
system. However, patients with low IgG titers should be retested three to four weeks 
after initial sampling to demonstrate a possible rise of IgG titers in paired sera. 
Cat scratch disease (CSD) has traditionally been 
diagnosed in patients with regional lymphadeno- 
pathy if three of the following criteria are met: con- 
tact with a cat and the presence of a scratch or a 
primary lesion; negative studies for other possible 
causes of lymphadenopathy; a positive skin test; 
and characteristic histopathological findings (1). 
By means of culture and the polymerase chain re- 
action (PCR), Bartonella henselae has been recent- 
ly recognized as the major causative agent of 
CSD (2, 3). The CSD skin test has been shown to 
have a lower sensitivity than PCR for Bartonella 
henselae and may, for this and for safety reasons, 
have lost its usefulness (4). Histopathological 
analyses are only possible following surgical biop- 
sy. Serology has made important contributions to 
recognition of the causative agent (5), epidemio- 
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logical studies (6), and a better delineation of the 
clinical spectrum of CSD (7). Thus, serology may 
become the simplest and most feasible way to di- 
agnose CSD, provided the tests are reliable (8). 
We recently demonstrated the intracellular loca- 
tion of Bartonella henselae after cocultivation 
with Vero cells. Fixed slides with monolayers of 
Vero cells with intracellular Bartonella henselae 
were used in an indirect immunofluorescence 
assay (IFA) for detecting immunoglobulin G
(IgG) to Bartonella henselae (9). The workload 
associated with cocultivation of Bartonella hense- 
lae with Vero cells on chamber slides for the in- 
house IFA was considered reasonable as long as 
no alternatives were available. In the meantime, 
several commercial slides for IFA have been de- 
veloped for the detection of IgG to Bartonella 
henselae. In the present study we compared our in- 
house IFA with four commercial IFAs. Further- 
more, we determined the diagnostic value of one 
commercial IFA with Vero cell-associated Barto- 
nella henselae. 
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Table 1: Immunoglobulin G titers to Bartonella henselae of 58 persons from the rural region determined by indirect immuno- 
fluorescence with four commercial slides and an in-house slide. 
Agar-derived Cetl-associated 
Titer MRL-BA Virion Bion MRL-Vero In-house 
< 1:64 6 7 20 25 24 
1:64 12 7 27 20 29 
1:128 14 14 9 10 3 
1:256 7 9 1 2 2 
1:512 14 16 1 1 
1:1024 3 4 
1:2048 2 1 
Material and Methods 
Serum Specimens'. Fifty-eight sera (supplied by J. Zihler in 
1994, stored at -20~ from individuals living in a rural region 
in central Switzerland were tested for IgG antibodies to Bar- 
tonella henselae with four commercial IFAs and the results 
compared with those obtained with our in-house system. The 
individuals had consulted their physicians because of symp- 
toms not suggestive of CSD. Thirty-three of them were cat 
owners. Eight sera from four patients with lymphadenopathy 
who, after cat contact, presented a clear rise of IgG against 
Bartonella henselae with the in-house IFA, were included in 
this comparison. 
Sera collected from 1994 to 1996 from 22 patients with CSD 
(age range, 3-35 years; mean, 13 years), 20 immunocompetent 
childrer~ with tymphadenopathy without CSD, 100 blood 
donors from Zurich (urban area; supplied by R Schenker in 
1994), and 120 blood donors from Aarau (mixed urban/rural 
area; supplied by K. Giger in 1994) were tested with a 
commercial cell-associated IFA. Sera were stored at -20~ 
Sera from 15 of the 22 patients with CSD and from the blood 
donors had been tested previously with the inhouse system 
(10). The remaining seven patients with CSD had either 
subacute lymphadenitis with typical histopathological 
changes or a positive PCR for Bartonella henselae. 
Indirect Immunofluorescence Assay. Immunoglobulin G to 
BartoneUa henselae was detected by an IFA with in-house 
slides and the following four commercial slides: MRL-BA 
slides (prototype #4, lot #R017194; MRL Diagnostics, USA); 
Virion slides (experimental ot #B:381718.09; Institut 
Virion, Switzerland) containing blood agar-derived Bartonel- 
la henselae; MRL-Vero slides (lot #R049395, lot #R067095, 
and lot #R028196, Bartonella IgG substrate slides, MRL Diag- 
nostics); and Bion slides (Bios, Germany) containing cell- 
associated Bartonella henselae. Each of the MRL-BA and 
MRL-Vero slides with eight wells contained one test field 
with Bartonella henselae and one test field with Bartonella 
quintana. Results of the IFA for Bartonella quintana were not 
evaluated. The in-house slides were based on intracellular 
Bartonella henselae cocultivated with Vero cells as described 
previously (9). In brief, Bartonella henselae (strain G-5436; 
kindly provided by R. Weyant, Centers for Disease Control 
and Prevention, Atlanta, USA) was cocultivated with Veto 
ceils in tissue chamber slides. After two days the sIides were 
fixed with acetone-ethanol (1:1) and used for the IFA. 
Sera were overlaid onto the slides at dilutions of 1:64 (if nec- 
essary, up to 1:2048) and allowed to rest for 30 min at 37~ 
After washing, IgG was detected by a fluorescein-isothio- 
cyanate (FITC)-anti-human IgG conjugate for 30 min at 
37~ For Virion slides the conjugate (lot 396318.02; Virion) 
was diluted 1:10; the conjugates for MRL-BA and MRL-Vero 
slides (goat anti-human IgG FITC; Tago Immunotogicals, 
Biosource International, USA) and for Bion and in-house 
slides (Fluoline G; bioM6rieux, Switzerland) were diluted 
1:100. After incubation for 30 rain the slides were washed and 
examined with a fluorescence microscope. The endpoint iter 
was defined as the dilution that still presented a specific 
fluorescence. 
Statistical Calculations. The optimal cut-off for the commer- 
cial Vero cell-associated IFA evaluated was chosen according 
to the balance desired between sensitivity and specificity (11). 
Results 
The compar ison of commerc ia l  with in-house 
slides for the determinat ion of IgG titers to Bar- 
tonella henselae by IFA  is shown in Table 1. 
Among the 58 individuals f rom the rural region, 
titers of _> 1:256 were detected with the agar- 
der ived MRL-BA and Vir ion slides in 26 (44.8%) 
and 30 (51.7%) sera and titers of < 1:64 in six 
(10.3%) and seven (12%) sera, respectively. In 
contrast, when employing Bion, MRL-Vero,  and 
in-house slides with cel l-associated Bartonella 
henselae, titers of _> 1:256 were found in two 
(3.4%), three (5.1%), and two (3.4%) sera and tit- 
ors of < 1:64 in 20 (34.5%), 25 (43.1%), and 24 
(41.5%) sera, respectively. With Bion slides 97% 
of the titers were within one log 2 di lution of the 
corresponding titers obta ined with the in-house 
system; with MRL-Vero  slides all titers were 
within one log 2 di lution and 72.4% were identical 
to those of the in-house system. However,  with the 
two commercial  slides with agar-derived Bartonel- 
la henselae, 60.3% of all sera had titer differences 
of two or more  log 2 dilutions compared to titers 
obtained with the in-house IFA. 
Thirty-three of the 58 individuals were cat own- 
ers. Using any slides with cell-associated Bartonel- 
la henselae, cat owners more  frequently had titers 
of > 1:64 than persons without cats (p < 0.05, 
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Table 2: Comparison of immunoglobulin G titers in paired sera from four patients with cat scratch disease. Intervals between 
sera a and b were 42, 21, 24, and 14 days in patients 1, 2, 3, and 4, respectively. 
IgG titer 
MRL-BA Virion Bion MRL-Vero In-house 
Patient 1 a 1:128 1:256 1:512 1:512 1:256 
b 1:256 1:256 1:2048 1:1024 1:1024 
Patient 2 a 1:64 nd 1:128 1:512 1:128 
b 1:128 nd 1:512 1:512 1:512 
Patient 3 a 1:64 1:128 1: < 64 1:128 1:64 
b 1:128 1:512 1:256 1:1024 1:1024 
Patient 4 a 1:128 t:128 1:64 1:128 1:128 
b 1:256 1:256 1:256 1:1024 1:512 
Fisher's exact test; data not shown). With MRL- 
BA and Virion slides, the median titers were 
1:256 in cat owners and 1:128 in persons without 
cats; titers of 1:512 were more frequent in cat own- 
ers (p < 0.05, Fisher's exact test). Since a rise of 
IgG is a good marker for an ongoing infection, we 
included four pairs of sera in this comparison (Ta- 
ble 2). The slides with blood agar-derived Barto- 
nella henselae showed in only one patient a four- 
fold titer rise in paired sera and a higher titer than 
the corresponding median titer of cat owners. 
The Bion and MRL-Vero slides showed higher tit- 
ers than the median titers of cat owners in all four 
patients. 
The diagnostic value of the commercial Vero cell- 
associated MRL slides was further evaluated. 
Table 3 shows the IgG titers of 26 patients 
(including the first sera of the 4 patients from 
Table 2) with CSD and controls. All control pa- 
tients with lymphadenopathy without suspected 
CSD had titers of < 1:64, except one who had a 
titer of 1:128. Fourteen of 220 blood donors had 
titers of 1:256 and one a titer of 1:512. Blood do- 
nors from the mixed urban/rural area more fre- 
quently had IgG titers (50.8%) than blood donors 
from the urban area (37%) (p < 0.05, Fisher's ex- 
act test). For the serodiagnosis of CSD in our 
mixed urban/rural population, the IgG titer of 
1:256 had a sensitivity of 84.6% and a specificity 
of 93.4%. 
Discussion 
In the present comparison of commercial IFA 
slides, those containing cell-associated Bartonella 
henselae revealed lower IgG titers than slides 
containing blood agar-derived bacilli. Four patients 
included in this comparison had IgG titers to 
Bartonella henselae similar to those of the normal 
rural population when the agar-derived slides 
were used. We therefore excluded these slides 
from consideration for replacement of our in- 
house system. The Vero cell-associated MRL 
slides showed in 72% the same titer as the in- 
house slides and were further evaluated for detec- 
tion of IgG to Bartonella henselae. 
Sera from patients with and without CSD and 
from blood donors from two different geograph- 
Table 3" Immunoglobulin G titers to Bartonella henselae of patients with cat scratch disease (CSD), control patients, urban 
blood donors, and mixed urban/rural blood donors using the MRL-Vero slides. When a titer of 1:512 is used as the cut-off, 
sensitivity is 61.5% and specificity 99.6%; with 1:256 as the cut-off, sensitivity is 84.6% and specificity 93.4%; with 1:128 
as the cut-off, sensitivity is 100% and specificity 83.4%. 
Patients Patients Urban Urban/rural 
IgG with CSD without CSD blood donors blood donors 
titer (n = 26) (n = 20) (n = 100) (n = 120) 
1 : < 64 19 63 59 
1:64 19 40 
1:128 4 1 14 10 
1:256 6 4 10 
1:512 10 1 
1:1024 6 
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ical regions were included in this evaluation. To 
achieve a specificity of over 90%, the titer of 1:256 
was chosen as the cut-off. The titer of 1:128 would 
have had a specificity below 85 % but a sensitivi- 
ty of 100%. Others have found that a cut-off titer 
of 1:100 with a cell-associated system is not sensi- 
tive enough (40.6%) to confirm a CSD diagnosis; 
the low sensitivity was attributed to blood sam- 
pling before an antibody increase had occurred 
(12). However, the positive predictive value of a 
titer of 1:100 with the same IFA was only 68.2% 
(13). A cell-associated IFA with the new Bartonel- 
la henselae serovariant "Marseille" revealed in 
three of 100 healthy blood donors a titer of 1:200, 
which was considered the cut-off titer (14). In a 
previous study, 11 patients with a Bartonella 
henselae infection (proven by PCR or character- 
istic histopathological findings) had titers of 
1:256 or higher with the in-house IFA (15). In a 
further study with the in-house system, titers of 
1:512 or higher were found in 20 of 20 children 
presenting with subacute lymphadenopathy and a 
history of recent cat scratch (10). In three of 
these CSD patients, the initial titers were only 
1:128 and 1:256, but within three weeks a rise to 
1:1024 was noted. By contrast, in only one of the 
332 controls (including 43 persons from house- 
holds of the patients) was a titer of 1:512 found 
(10). 
Our most important observation was the differ- 
ence in IgG titers obtained with the various com- 
mercial slides, depending on the antigen prepara- 
tion. It was recently shown in one patient hat tit- 
ers to Bartonella henselae differed greatly, 
depending on the antigen preparation for the 
IFA: the patient had a titer of 1:12,800 against a 
sheep blood agar strain and a titer of 1:200 
against he same strain cultivated on endothelial 
cells (14). A similar discrepancy was described for 
IgG antibodies against Bartonella quintana 
grown on sheep blood agar and human epithelial 
cells (16).The first IFA to detect IgG to Bartonel- 
la henselae was based on cocultivation with Vero 
cells to inhibit autoagglutination of Bartonella 
henselae (5). The present study showed that cocul- 
tivation improves the specific detection of IgG to 
Bartonella henselae. The reasons for this are un- 
known, but antigenic proteins could perhaps 
change during cocultivation. Such changes are 
suggested uring phase variation (17). The intra- 
cellular location of Bartonella henselae in the two 
commercial cell-associated slides (MRL-Vero 
and Bion) can be assumed because the specific 
fluorescence had the same granular aspect as 
shown previously with our in-house slides (9). 
Besides the antigen preparation of Bartonella 
henselae, pidemiological parameters affect he se- 
rodiagnosis of Bartonella henselae infection (18). 
In all IFA systems erum samples of people report- 
ing cat contact had higher titers than sera of per- 
sons without cat contact. In line with our previous 
study of the in-house system (10), we also 
found by means of the MRL-Vero slides a higher 
seroprevalence in blood donors from the mixed 
urban/rural population than in those from the 
city. This could be explained by close cat contact 
in rural regions. Low IgG titers could relate to un- 
apparent or past infection with Bartonella hense- 
lae. Finally, serodiagnosis can be influenced by 
cross-reacting antibodies against other bacterial 
antigens, e.g., Bartonella with Coxiella (19) and 
other ~-2 protobacteria (20). 
We conclude that, using the MRL-Vero slides, a 
titer of 1:256 is compatible with CSD in our 
mixed urban/rural population. For routine pur- 
poses, the MRL-Vero slides can replace our in- 
house system. Until tests to detect IgM to Barto- 
nella henselae have been thoroughly evaluated, 
patients with clinical signs and symptoms of 
CSD plus low specific IgG titers should have 
paired sera drawn in intervals of three to four 
weeks in order to detect apossibly significant an- 
tibody rise. We believe that serology may replace 
traditional diagnostic riteria for CSD (8,10), but 
histology and PCR may still be necessary in 
atypical clinical situations. 
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